Zurich Insurance Group

Zurich Insurance Group is a multi-line insurance company. Co. provides a range of general insurance and life insurance products and services, serving individuals, small businesses, and mid-sized and large companies, including multinational corporations, in more than 170 countries. Co.'s business segments include: General Insurance, which provides property and casualty insurance and services, risk insights; Global Life, which provides protection, savings and investment solutions; and Farmers, which provides management services related to property and casualty insurance.
  • TickerZURN
  • ISINCH0011075394
  • ExchangeSix Swiss Exchange
  • SectorNonlife Insurance
  • CountrySwitzerland

Analysts

With a more favourable environment, ZURICH INSURANCE GP.AG improves to Slightly Positive

ZURICH INSURANCE GP.AG (CH), a company active in the Full Line Insurance industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date June 21, 2019, the closing price was CHF 340.10 and its potential was estimated at CHF 357.11.

1 director sold

A director at Zurich Insurance Group AG sold 3,000 shares at 337.305CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The na...

Benoit Valleaux

Zurich Insurance : Un mix d’activités attractif, mais déjà valorisé par le marché

Zurich Insurance est le 4ème assureur composite européen en termes de primes. Son mix d'activités équilibré offre une bonne visibilité sur sa génération de capital. De plus, sa rentabilité structurelle en assurance dommages est en amélioration et le groupe est en bonne voie pour atteindre ses objectifs financiers 2019. Pour autant les bonnes dynamiques opérationnelles nous semblent déjà intégrées par le consensus et le potentiel de hausse du titre est limité. Nous initions ainsi ...

Benoit Valleaux

Zurich Insurance : An attractive business mix, but already priced in by the market

Zurich Insurance is Europe’s fourth-largest composite insurer by premiums. Its balanced business mix offers good visibility on its capital generation. Furthermore, its structural profitability in P&C insurance is improving and it is on track to achieve its 2019 financial targets. However, the consensus seems to have already factored in the good operating momentum and upside for the share is limited. We therefore initiate coverage of the stock at Neutral. - >A diversified a...

Henry Heathfield

Morningstar | ZURN Updated Forecasts and Estimates from 17 May 2019

Zurich Insurance reported what we think are decent headline numbers for the first quarter. Having rolled our model and incorporated what we think is a better outlook for the nonlife division, we are increasing our fair value estimate to CHF 350 per share. We maintain our narrow moat rating. Having been in a state of almost paralysis, the North America nonlife division reported gross written premium growth of 100 basis points and rate rises equal to 400 basis points. With the outlook for this business continuing to rise, at the moment we think we are about right in terms of forecasts for gross...

Jean-Christophe Dourret

Zurich Insurance Group : Zurich Insurance - 31 May 2018

...

Jean-Christophe Dourret

Zurich Insurance Group : Zurich Insurance - 31 mai 2018

...

Benoit Valleaux

Zurich Insurance : Un mix d’activités attractif, mais déjà valorisé par le marché

Zurich Insurance est le 4ème assureur composite européen en termes de primes. Son mix d'activités équilibré offre une bonne visibilité sur sa génération de capital. De plus, sa rentabilité structurelle en assurance dommages est en amélioration et le groupe est en bonne voie pour atteindre ses objectifs financiers 2019. Pour autant les bonnes dynamiques opérationnelles nous semblent déjà intégrées par le consensus et le potentiel de hausse du titre est limité. Nous initions ainsi ...

Benoit Valleaux

Zurich Insurance : An attractive business mix, but already priced in by the market

Zurich Insurance is Europe’s fourth-largest composite insurer by premiums. Its balanced business mix offers good visibility on its capital generation. Furthermore, its structural profitability in P&C insurance is improving and it is on track to achieve its 2019 financial targets. However, the consensus seems to have already factored in the good operating momentum and upside for the share is limited. We therefore initiate coverage of the stock at Neutral. - >A diversified a...

Henry Heathfield

Morningstar | ZURN Updated Forecasts and Estimates from 17 May 2019

Zurich Insurance reported what we think are decent headline numbers for the first quarter. Having rolled our model and incorporated what we think is a better outlook for the nonlife division, we are increasing our fair value estimate to CHF 350 per share. We maintain our narrow moat rating. Having been in a state of almost paralysis, the North America nonlife division reported gross written premium growth of 100 basis points and rate rises equal to 400 basis points. With the outlook for this business continuing to rise, at the moment we think we are about right in terms of forecasts for gross...

Henry Heathfield

Morningstar | Decent 1Q for Zurich; Shares Marginally Undervalued

Zurich Insurance reported what we think are decent headline numbers for the first quarter. Having rolled our model and incorporated what we think is a better outlook for the nonlife division, we are increasing our fair value estimate to CHF 350 per share. We maintain our narrow moat rating. Having been in a state of almost paralysis, the North America nonlife division reported gross written premium growth of 100 basis points and rate rises equal to 400 basis points. With the outlook for this business continuing to rise, at the moment we think we are about right in terms of forecasts for gross...

Henry Heathfield

Morningstar | Decent 1Q for Zurich; Shares Marginally Undervalued. See Updated Analyst Note from 15 May 2019

Zurich Insurance reported what we think are decent headline numbers for the first quarter. Having rolled our model and incorporated what we think is a better outlook for the nonlife division, we are increasing our fair value estimate to CHF 350 per share. We maintain our narrow moat rating. Having been in a state of almost paralysis, the North America nonlife division reported gross written premium growth of 100 basis points and rate rises equal to 400 basis points. With the outlook for this business continuing to rise, at the moment we think we are about right in terms of forecasts for gross...

1 director sold

A director at Zurich Insurance Group AG sold 3,000 shares at 337.305CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The na...

With a more favourable environment, ZURICH INSURANCE GP.AG improves to Slightly Positive

ZURICH INSURANCE GP.AG (CH), a company active in the Full Line Insurance industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date June 21, 2019, the closing price was CHF 340.10 and its potential was estimated at CHF 357.11.

Zurich Insurance Group

Zurich Insurance Group

Zurich Insurance Group

Zurich Insurance Group

MarketLine Department

Allianz SE - Strategy, SWOT and Corporate Finance Report

Summary Allianz SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Allianz SE (Allianz) is one of the leading global insurers, offering life, and property and casualty (P&C) insurance products, under the Allianz and Euler Hermes brands. Its insurance offerings cover motor, liability, homeowner, accident, travel and assistance, marine, aviation and transport. It ...

MarketLine Department

Aviva Plc - Strategy, SWOT and Corporate Finance Report

Summary Aviva Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Aviva Plc (Aviva) is a provider of life insurance, general and health insurance, and fund management services. Its offering includes life and savings plans, pension plans, long-term health and accident insurance, and annuity plans. It also provides insurance products for property and liability, me...

MarketLine Department

AXA SA - Strategy, SWOT and Corporate Finance Report

Summary AXA SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights AXA SA (AXA) is an insurance company, offering both life and non-life insurance products. It offers life insurance and savings products such as individual life insurance, group life insurance, health and personal protection products, and individual and group savings retirement products. It also offer...

Olivier Pauchaut

Insurance & Fintech: Satisfactory renewals for Scor, decent FY numbers for Zurich

Insurance & Fintech Satisfactory renewals for Scor, decent FY numbers for Zurich SCOR: satisfactory Jan. renewals, heavy Q4 natcat losses ZURICH: decent FY numbers, as expected

MarketLine Department

Principal Financial Group Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Principal Financial Group Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Principal Financial Group Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its c...

Zurich Insurance Group – Proxinvest Corporate Governance Rating ® : B

Proxinvest Corporate Governance Rating ® helps investors integrate governance into their investment decision and identify governance risks and opportunities within their portfolio. Proxinvest Corporate Governance Rating ® Service rates European issuers through the analysis of four main themes : Ownership & Shareholder rights, Board & Committees, Audit & Process, Remuneration. Each theme is rated taking into account several comprehensive sub-categories. Our unique two-step process to achieve each rating includes a first step quantitative valuation and a second step qualitative filter...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Int'l Compass: Global Equity Strategy

Europe & the UK remain in focus The MSCI ACWI ex-U.S. is breaking topside its nearly 14-month downtrend and above key resistance. The move is being fueled by improvements throughout most of Europe and the UK, along with strength in China over the past 2-3 months. We believe these positive developments are supportive of higher equity prices moving forward. As a result of these and several other observations highlighted below, our outlook on global equities is positive. • Europe & the UK. As has been the case over the last several weeks, a major focus of ours within global equities (ex-U.S.) h...

Jérôme VINERIER

Short term view - ZURICH INSUR : The background trend is clearly bullish.

The background trend is clearly bullish. Prices are still making progress but there is less power in the movement. The next resistance is at CHF 320.00. Breaking below the support at CHF 288.90 would invalidate the trend.

Jérôme VINERIER

Analyse court terme - ZURICH INSUR : La tendance de fond est clairement orientée à la hausse.

La tendance de fond est clairement orientée à la hausse. Les cours progressent encore, mais le mouvement montre moins de puissance. La prochaine résistance est à 320,00 CHF. La rupture du support à 288,90 CHF invaliderait cette tendance.

Matthieu DRIOL

Short term view - ZURICH INSUR : The background trend is clearly bullish.

The background trend is clearly bullish. Prices are still making progress but there is less power in the movement. The next resistance is at CHF 306.40. Breaking below the support at CHF 290.20 would invalidate the trend.

Matthieu DRIOL

Analyse court terme - ZURICH INSUR : La tendance de fond est clairement orientée à la hausse.

La tendance de fond est clairement orientée à la hausse. Les cours progressent encore, mais le mouvement montre moins de puissance. La prochaine résistance est à 306,40 CHF. La rupture du support à 290,20 CHF invaliderait cette tendance.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch